Health Panama Launches Nirsevimab Antibody Program to Protect Infants from RSV
Panama's Ministry of Health (Minsa) has launched the rollout of nirsevimab, a long-acting monoclonal antibody designed to prevent severe respiratory syncytial virus (RSV) disease in newborns and infants, according to official announcements. Health personnel…